Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akira Tanimura
Institution:
Tokyo-Kita Medical Center
Observed institutions:
National Center for Global Health and Medicine,
Tokyo-Kita Medical Center
ORCID:
0000-0003-0394-7032
Observed ORCID:
0000-0003-0394-7032
OpenAlex ID:
A5102825840
A Case of polychondritis-onset refractory organizing pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of 7 years
2021
·
Maki Sakuma
, Akira Tanimura
, et al.
·
Rheumatology
·
28
Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy
2016
·
Takashi Matono
, Kayoko Hayakawa
, et al.
·
BMC Research Notes
·
16
PDF
The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma
2018
·
Akira Tanimura
, Risen Hirai
, et al.
·
Internal Medicine
·
13
PDF
Autologous Stem Cell Transplantation using MEAM Regimen for Relapsed AIDS-Related Lymphoma Patients Who Received Highly Active Anti-Retroviral Therapy: A Report of Three Cases
2009
·
Kimihito C Kawabata
, Shotaro Hagiwara
, et al.
·
Internal Medicine
·
10
PDF
Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide as a Salvage and Bridging Regimen before Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma
2022
·
Tomiteru Togano
, Shohei Andoh
, et al.
·
Internal Medicine
·
9
PDF
Improved progression-free and event-free survival in myeloma patients undergoing PBSCH receiving a cyclophosphamide + G-CSF regimen than G-CSF alone
2018
·
Akira Tanimura
, Risen Hirai
, et al.
·
International Journal of Hematology
·
8
Efficacy and Safety of VTD-PACE Regimen in Relapsed or Refractory Multiple Myeloma
2017
·
Shohei Andoh
, Tomiteru Togano
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
Blastic Plasmacytoid Dendritic Cell Neoplasm Developed in Chronic Myeloid Leukemia in Molecular Remission During a Four-Year Treatment-Free Interval After Six Years of Dasatinib Treatment
2024
·
Hiroshi Suzuki
, Masataka Takeshita
, et al.
·
Cureus
·
2
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study
2011
·
Akiyoshi Miwa
, Naohiro Sekiguchi
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
2
[Posterior reversible encephalopathy syndrome during nilotinib treatment for chronic myeloid leukemia].
2023
·
Daisuke Kudo
, Hiroshi Suzuki
, et al.
·
PubMed
·
1
Genetic Landscape of BPDCN Arising in CML Remission
2022
·
Masataka Takeshita
, Nobuyuki Kodama
, et al.
·
Blood
·
1
Efficacy of VRD(Bortezomib, Lenalidomide, and Dexamethasone) Consolidation Therapy and Maintenance Therapy with Immunomodulatory Drugs(Thalidomide or Lenalidomide) after Autologous Peripheral Blood Stem Cell Transplantation in the Era of Bortezomib-Containing Induction Therapy-A Single Institution Experience.
2020
·
Akira Tanimura
, Risen Hirai
, et al.
·
PubMed
·
1
The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases
2013
·
Sohtaro Mine
, Shotaro Hagiwara
, et al.
·
Blood
·
1
Requirements for achievement of treatment-free remission in long-term survivor of multiple myeloma
2025
·
Masataka Takeshita
, Nobuyuki Kodama
, et al.
·
Blood
Impact of Combining Frailty Assessment Systems to Select Elderly Myeloma Patients Eligible for Autologous Peripheral Blood Stem Cell Transplantation
2019
·
Akira Tanimura
, Koji Okazaki
, et al.
·
Blood
Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents
2013
·
Shotaro Hagiwara
, Risen Hirai
, et al.
·
Blood
What Is the Appropriate Dose Attenuation System of RCHOP for Elderly DLBCL Patients? - A Single Institutional Analysis in 115 Cosecutive Patients From Japan -
2012
·
Akira Tanimura
, Risen Hirai
, et al.
·
Blood
High-Dose Cyclophosphamide + G-CSF Mobilization Regimen Have Higher Anti-Myeloma Effects Than G-CSF Alone Regimen – Single Institutional Study in 147 Myeloma Patients From Japan
2011
·
Akira Tanimura
, Masataka Takeshita
, et al.
·
Blood
Multi-Organ Involvement of Multiple Myeloma Cells In the Cases of Recent 10 Years: A Clinicopathologic Study of 81 Consecutively Autopsied Cases
2010
·
Shotaro Hagiwara
, Makoto Mochizuki
, et al.
·
Blood
Direct Myeloma Cell Invasion as One of the Major Causes of Renal Impairment In Myeloma A Pathological Analysis of Renal Findings In 41 Autopsied Cases
2010
·
Amane Tagashira
, Junichiro Takano
, et al.
·
Blood
Intensified Conditioning Regimen Has Only Limited Value for Patients with Progressive Multiple Myeloma
2003
·
Naoki Takezako
, Akiyoshi Miwa
, et al.
·
International Journal of Hematology
Show more works
View as search
Works count:
21
Citation count:
102
H-index:
6
I10-index:
4
Year
Topic
Type